Marie-Line Clary-Ceccato

Title: Marie-Line Clary-Ceccato: Innovator in FGFR Agonist Compounds

Introduction

Marie-Line Clary-Ceccato is a notable inventor based in Paris, France. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target fibroblast growth factor receptors (FGFR). Her innovative work has the potential to impact therapeutic applications in various medical fields.

Latest Patents

Marie-Line Clary-Ceccato holds a patent for "FGF receptor (FGFR) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof." This invention relates to novel heterocyclic compounds, specifically pyrazolopyridine derivatives, that induce FGFR dimerization. The compounds have the general formula: M-L-Min, where M and M may be identical or different, and L represents a linker group that covalently links M and M. This patent highlights her expertise in creating compounds with therapeutic potential.

Career Highlights

Throughout her career, Marie-Line has worked with prominent companies, including Sanofi. Her experience in the pharmaceutical industry has allowed her to develop innovative solutions that address critical health challenges.

Collaborations

Marie-Line has collaborated with Nathalie Guillo, who is also a talented professional in the field. Their partnership has contributed to advancements in their research and development efforts.

Conclusion

Marie-Line Clary-Ceccato is a distinguished inventor whose work on FGFR agonist compounds showcases her innovative spirit and dedication to advancing medical science. Her contributions are poised to make a lasting impact in the field of therapeutics.